
Lauren Shaff, MD, contextualizes results from a phase 1 study evaluating copanlisib plus ibrutinib in relapsed/refractory primary and secondary CNS lymphoma.

Your AI-Trained Oncology Knowledge Connection!

Lauren Shaff, MD, is a neuro-oncologist and associate director of the Neuro-Oncology Fellowship Program at Memorial Sloan Kettering Cancer Center.

Lauren Shaff, MD, contextualizes results from a phase 1 study evaluating copanlisib plus ibrutinib in relapsed/refractory primary and secondary CNS lymphoma.

Published: November 24th 2025 | Updated: